Zobrazeno 1 - 10
of 118
pro vyhledávání: '"Peritoneal Malignant Mesothelioma"'
Publikováno v:
Pathology and Oncology Research, Vol 29 (2024)
Background: Malignant mesothelioma (MM) is a tumor originating from the pleura, peritoneum, or pericardial cavity. It is divided into diffuse and localized malignant mesothelioma, with four subtypes in diffuse MM: epithelioid, sarcomatoid, desmoplast
Externí odkaz:
https://doaj.org/article/0f1bc8a3352a4db599aec5f602d0bc4f
Autor:
Saliha Sağnıç, Özer Birge, Anıl Alpsoy, Selen Doğan, Hasan Aykut Tuncer, Elif Peştereli, Tayup Şimşek
Publikováno v:
Journal of Obstetrics and Gynaecology, Vol 43, Iss 1 (2023)
Externí odkaz:
https://doaj.org/article/9b4f48b1853e4685a75d6667eaf77766
Autor:
Ruchita Tyagi, Pavneet Kaur Selhi, Ramit Mahajan, Bhavna Garg, Harpreet Kaur, Navita Gupta, Ankita Soni
Publikováno v:
Journal of the American Society of Cytopathology. 11:40-45
Introduction Peritoneal malignant mesothelioma is an extremely rare tumor and is a difficult diagnosis to be made on cytology alone. We report 3 cases where the cytologic features were misdiagnosed as carcinoma/lymphoma but histopathology and immunoh
Autor:
Amy Ford, Calley Middleton, L. Campbell, Petra Jankowska, Gary Dougherty, Gillian Price, Aarti Gaba, Charlotte Poile, Sam Chan, Sarah Danson, Sean Ewings, Jason F. Lester, Gareth Griffiths, Paul Shaw, Mavis Nye, Mathilda Cominos, Dionysis Papadatos, Jay Naik, Jill Gardiner, Joanne Lord, Cathy J. Richards, Meenali Chitnis, Gerard G Hanna, Peter Wells-Jordan, Raffaele Califano, Lucy Johnson, Carol MacGregor, Dean A. Fennell, Andy Polychronis, Gairin Dancey, Kayleigh Hill, Angela Scott, Liz Darlison, Tom Geldhart, Nicola Steele, Judith Cave, Christian H. Ottensmeier, Lois Mullholand, Peter W. Szlosarek
Publikováno v:
LANCET ONCOLOGY
The Lancet. Oncology
The Lancet. Oncology
Background: no phase 3 trial has yet shown improved survival for patients with pleural or peritoneal malignant mesothelioma who have progressed following platinum-based chemotherapy. The aim of this study was to assess the efficacy and safety of nivo
Publikováno v:
Acta Oncologica. 60:1250-1256
Background Mesothelioma of the pleural or peritoneal cavities is one of the deadliest cancer types. The incidence of pleural subtypes has decreased over time due to decrease in asbestos exposure, and the current treatment landscape is changing due to
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Aya Shinozaki-Ushiku, Katsutoshi Oda, Shinji Kohsaka, Hidenori Kage, Jun Nakajima, Hiroyuki Mano, Kiyoshi Miyagawa, Tetsuo Ushiku, Hiroyuki Aburatani
Publikováno v:
Pathology International. 70:775-780
We report a case with a rare combination of synchronous lung adenocarcinoma and bilateral malignant pleural mesotheliomas in a 70-year-old male without asbestos exposure. He metachronously developed peritoneal malignant mesothelioma, intrahepatic cho
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
David B. Chapel, Michelle S. Hirsch
Publikováno v:
The American journal of surgical pathology. 46(2)
Primary peritoneal malignant mesothelioma (MM) can demonstrate morphologic overlap with low-grade and high-grade tubo-ovarian serous neoplasms; it is also biologically and prognostically distinct from benign mesothelial proliferations. Currently, the